(Q46377272)

English

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

type 2 diabetes

0 references

insulin detemir

1 reference

based on heuristic

inferred from title

Domingo Orozco-Beltran

object named as

D Orozco-Beltran

11

0 references

object named as

K Khunti

1

0 references

author name string

S Caputo

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

T Damci

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

G J Dzida

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

Q Ji

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

M Kaiser

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

E Karnieli

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

A Liebl

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

R J Ligthelm

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

A Nazeri

10

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

C Pan

12

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

S A Ross

13

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

A L Svendsen

14

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

J Vora

15

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

J-F Yale

16

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

L F Meneghini

17

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

SOLVE Study Group

18

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

publication date

30 August 2012

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

14

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

12

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

1129-1136

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Insulin detemir: A historical perspective on a modern basal insulin analogue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Barriers to insulin initiation and intensification and how to overcome them

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Long-term effects of intensive glucose lowering on cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Megatrials in type 2 diabetes. From excitement to frustration?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Insulin analogues: how observational studies provide key insights into management of patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01665.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2012.01665.X

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/22830956

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46377272&oldid=2108697764"